Evidence map›Paper›PMID 18412279›Full record

ArticleHuman mutation2008

A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency.

Eduardo Lopez-Granados, Jeffrey E Keenan, Matthew C Kinney, Harvey Leo, Neal Jain, Chi A Ma, Ralph Quinones, Erwin W Gelfand, Ashish Jain

Abstract readCase Reports
In one paragraph

Article in Human mutation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 96 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Article
  2. Monogenic disorders of the TNF signalling pathway.Nature reviews. Rheumatology · 2026
    Review
  3. Hyperimmunoglobulin syndromes: A review of HIGM, HIES, and HIDS.Journal of translational autoimmunity · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Interstitial Lung Disease in Immunocompromised Children.Diagnostics (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eduardo Lopez-GranadosLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA.
Jeffrey E Keenan
Matthew C Kinney
Harvey Leo
Neal Jain
Chi A Ma
Ralph Quinones
Erwin W Gelfand
Ashish Jain
University of Colorado Denver · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

The Genetics, Pathogenesis, and Treatment of Primary ImmunodeficiencyZIAAI000924 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JAIN, ASHISH · 2009 to 2013
$4.8M
Studies of Hyper- IgM SyndromeZIAAI001078 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JAIN, ASHISH · 2009 to 2011
$1.2M
Intramural NIH HHS ZIA AI000924
6 · The paper itself

Abstract

Alterations in nuclear factor kappa B (NF-kappaB) essential modulator (NEMO; HUGO-approved symbol IKBKG) underlie most cases of ectodermal dysplasia with immune deficiency (EDI), a human disorder characterized by anhidrosis with diminished immunity. EDI has also been associated with a single heterozygous mutation at position Ser32 of the NF-kappaB inhibitor IkappaBalpha, one of two phosphorylation sites that are essential for targeting IkappaBalpha for proteasomal degradation and hence for activation of NF-kappaB. We report a novel heterozygous nonsense mutation in the IKBA (HUGO-approved symbol, NFKBIA) gene of a 1-year-old male child with EDI that introduces a premature termination codon at position Glu14. An in-frame methionine downstream of the nonsense mutation allows for reinitiation of translation. The resulting N-terminally truncated protein lacks both serine phosphorylation sites and inhibits NF-kappaB signaling by functioning as a dominant negative on NF-kappaB activity in lymphocytes and monocytes. These findings support the scanning model for translation initiation in eukaryotes and confirm the critical role of the NF-kappaB in the human immune response.

Indexed as

Codon, NonsenseAmino Acid SequenceEctodermal DysplasiaHumansI-kappa B KinaseI-kappa B ProteinsImmunologic Deficiency SyndromesInfantMaleMolecular Sequence DataNF-kappa BNF-KappaB Inhibitor alphaProtein BiosynthesisT-LymphocytesCodon, NonsenseI-kappa B KinaseI-kappa B ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, human

Identifiers

PMID18412279
PMCPMC3179847
OpenAlexW2014357942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.